References
- Bernstein J. R., Miller B. J., Franklin R. B. The disposition of 14C‐LY195115 (1,3‐dihydro‐3,3‐dimethyl‐5‐‘1,4,5,6‐tetrahydro‐6‐oxo‐3‐pyridazinyl‐6‐14C‐’‐2H‐indol‐2‐one), a potent cardiotonic drug, in several animal species. Federation Proceedings 1986; 45: 935, abstract # 4540
- Hayes J. S., Pollock G. J., Wilson H., Bowling N., Robertson D. W. Pharmacology of LY195115: A potent, orally‐active cardiotonic with a long duration of action. Journal of Cardiovascular Pharmacology 1987; 9: 425–434
- Robertson D. W., Krushinski J. H., Beedle E. E., Wyss V., Pollock D. G., Wilson H., Kauffman R. F., Hayes J. S. Dihydropyridazinone cardiotonics: discovery and inotropic activity of 1,3‐dihydro‐3,3‐dimethyl‐5‐‘1,4,5,6‐tetrahydro‐6‐oxo‐3‐pyridazinyl’ ‐2H‐indol‐2‐one. Journal of Medicinal Chemistry 1986; 29: 1832–1840
- Vodicnik M. J., Franklin R. B., Elcombe C. R., Lech J. J. Sex steroids and drug metabolism: a sex‐related difference in hepatic microsomal ethoxyresorufin‐O‐deethylation in Sprague‐Dawley rats. Biochemical Pharmacology 1981; 30: 1091–1097